Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Urologic Neoplasms 2 Stomach Neoplasms 2 Brain Neoplasms 2 beta-Thalassemia 1 Urinary Bladder Neoplasms 1 Supratentorial Brain Tumor Surgery 1 Strabismus 1 Prostatic Neoplasms 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Post-operative Residual Curarization 1 Obesity 1 Neuromuscular Blockade 1 Neoplasms 1 Myasthenia Gravis 1 Hepatoblastoma 1 Endobronchial Metastases 1 Emergence Delirium 1 Delayed Emergence from Anesthesia 1

Interventions

Docetaxel 277 Prednisone 237 enzalutamide 177 Leuprolide 172 Radiotherapy 164 Abiraterone Acetate 154 Magnetic Resonance Spectroscopy 147 bicalutamide 137 Goserelin 134 Androgen Antagonists 111 Radiosurgery 101 acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide 100 apalutamide 79 abiraterone 77 gallium 68 PSMA-11 74 Specimen Handling 67 darolutamide 58 Gonadotropin-Releasing Hormone 58 Radiation 56 Triptorelin Pamoate 53 cabazitaxel 50 Zoledronic Acid 49 pembrolizumab 48 Radiotherapy, Intensity-Modulated 47 Flutamide 47 Brachytherapy 47 luprolide acetate gel depot 46 Standard of Care 45 Carboplatin 44 Estramustine 43

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Prostatic Neoplasms × Sugammadex × Clear all

NCT04854993 2023-01-25

RECIR

Fondazione Policlinico Universitario Agostino Gemelli IRCCS

Phase 3 Completed

Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡